Geraniol isolated from lemon grass to mitigate doxorubicin-induced cardiotoxicity through Nrf2 and NF-κB signaling

被引:19
|
作者
Younis, Nancy S. [1 ,2 ]
Elsewedy, Heba S. [1 ]
Soliman, Wafaa E. [3 ,4 ]
Shehata, Tamer M. [1 ]
Mohamed, Maged E. [1 ,5 ]
机构
[1] King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa 31982, Saudi Arabia
[2] Zagazig Univ, Pharmacol Dept, Zagazig 44519, Egypt
[3] King Faisal Univ, Coll Clin Pharm, Dept Biomed Sci, Al Hasa 31982, Saudi Arabia
[4] Delta Univ Sci & Technol, Fac Pharm, Microbiol & Immunol Dept, Gamasa, Egypt
[5] Zagazig Univ, Coll Pharm, Dept Pharmacognosy, Zagazig 44519, Egypt
关键词
Doxorubicin; Cardiotoxicity; Essential oil; Geraniol; RATS POSSIBLE MECHANISM; MYRTUS-COMMUNIS L; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; ESSENTIAL OIL; APOPTOSIS; ACTIVATION; PATHWAY;
D O I
10.1016/j.cbi.2021.109599
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Geraniol, a natural monoterpene, is a component of many plant essential oils. It contains many medicinal and pharmacological properties. Doxorubicin is an anticancer drug; however, its clinical usage is limited due to its cumulative and dose-dependent cardiotoxicity. This study investigates geraniol as a protective agent against doxorubicin-induced cardiotoxicity and explores possible underlying mechanisms of action. Methods: Male Sprague-Dawley rats were allocated into five groups. Groups 1 and 2 were administered saline and geraniol 200 mg/kg/day/orally, respectively, for 15 days. Group 3 was administered intraperitoneal doxorubicin (5 mg/kg/IP on the 5th, 10th and 15th days to achieve a cumulative dose of 15 mg/kg) to induce cardiotoxicity. The fourth and fifth groups were treated with either geraniol 100 mg/kg or 200 mg/kg orally and doxorubicin to equal the doxorubicin dose administered to Group 3. Results: Treatment with geraniol significantly ameliorated cardiac damage and restored serum cardiac injury marker levels in doxorubicin treated animals. Geraniol upregulated Nrf2 and HO-1 expression, elevated total antioxidant capacity, decreased the nuclear accumulation of kappa-light-chain enhancer of activated B cells (NF-kappa B), decreased the phosphorylation and degradation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (I kappa B alpha), suppressed tumor necrosis factor-alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), and interleukin-18 (IL-18) levels, and restored the levels of Bax and caspase-3 and 9 in heart tissue. Conclusion: Geraniol may function as a potential activator of nuclear factor erythroid 2-related factor 2 (Nrf2), which subsequently improves Nrf2-dependent antioxidative signaling, diminishes apoptosis and subdues the inflammatory response. The downstream result is protection of the heart from doxorubicin-induced cardiotoxicity.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Magnesium lsoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway
    Zheng, Bin
    Yang, Yakun
    Li, Jinghan
    Li, Jing
    Zuo, Saijie
    Chu, Xi
    Xu, Shan
    Ma, Donglai
    Chu, Li
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 543 - 556
  • [42] Genistein protects against doxorubicin-induced cardiotoxicity through Nrf-2/HO-1 signaling in mice model
    Bai, Zhifeng
    Wang, Zhijian
    ENVIRONMENTAL TOXICOLOGY, 2019, 34 (05) : 645 - 651
  • [43] MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice
    Fan, Di
    Chen, Hong-bin
    Leng, Yan
    Yang, Shi-jun
    CURRENT MEDICAL SCIENCE, 2022, 42 (01) : 48 - 55
  • [44] Triptriolide Alleviates Lipopolysaccharide-Induced Liver Injury by Nrf2 and NF-κB Signaling Pathways
    Yang, Yi-Qi
    Yan, Xiao-Teng
    Wang, Kai
    Tian, Rui-Min
    Lu, Zhao-Yu
    Wu, Li-Lan
    Xu, Hong-Tao
    Wu, Yun-Shan
    Liu, Xu-Sheng
    Mao, Wei
    Xu, Peng
    Liu, Bo
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [45] Treatment with catalpol protects against cisplatin-induced renal injury through Nrf2 and NF-κB signaling pathways
    Zhang, Jun
    Liu, Li
    Li, Furong
    Wang, Zongqian
    Zhao, Jinghong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (04) : 3025 - 3032
  • [46] Fucoidan alleviates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via Nrf2/GPX4 pathway
    Wang, Yizhi
    Han, Jiawen
    Zhan, Shifang
    Guo, Chenyu
    Yin, Shuangneng
    Zhan, Lin
    Zhou, Qianyi
    Liu, Ruiying
    Yan, Hua
    Wang, Xiaoyan
    Yan, Dan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 276
  • [47] Tirzepatide alleviates doxorubicin-induced cardiotoxicity via inhibiting HRD1-mediated Nrf2 ubiquitination
    Yang, Dan
    Chen, Yang-Hao
    Chen, Yan-Kun
    Zeng, Ya-Lin
    Ling, Zhi-Yu
    CARDIOVASCULAR RESEARCH, 2025,
  • [48] MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice
    Di Fan
    Hong-bin Chen
    Yan Leng
    Shi-jun Yang
    Current Medical Science, 2022, 42 : 48 - 55
  • [49] DL-3-n-butylphthalide attenuates doxorubicin-induced acute cardiotoxicity via Nrf2/HO-1 signaling pathway
    Li, Dengke
    Zhang, Wei
    Fu, Hui
    Wang, Xi
    Tang, Yanhong
    Huang, Congxin
    HELIYON, 2024, 10 (05)
  • [50] NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity
    Xu, Anji
    Deng, Feiyan
    Chen, Yongyi
    Kong, Yu
    Pan, Lijun
    Liao, Qianjin
    Rao, Zhen
    Xie, Luyuan
    Yao, Chaoling
    Li, Sha
    Zeng, Xiaoling
    Zhu, Xiaomei
    Liu, Huayun
    Gao, Nina
    Xue, Lei
    Chen, Fen
    Xu, Guoxing
    Wei, Di
    Zhou, Xiao
    Li, Zan
    Sheng, Xiaowu
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130